Associations Between Industry Sponsorship and Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment

被引：11
作者：
Lane, Jordan D. [1 ]
Friedberg, Mark W. [2 ]
Bennett, Charles L. [3 ]
机构：
[1] Walter Reed Natl Mil Med Ctr, Dept Anesthesiol, Bethesda, MD USA
[2] Brigham & Womens Hosp, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA
[3] Univ South Carolina, South Carolina Coll Pharm, 715 Sumter St,Coker Life Sci,Room 311, Columbia, SC 29208 USA
来源：
JAMA ONCOLOGY | 2016年 / 2卷 / 02期
关键词：
D O I：
10.1001/jamaoncol.2015.3928
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：274 / 276
页数：4
相关论文
共 5 条
  • [1] Evaluation of conflict of interest in economic analyses of new drugs used in oncology
    Friedberg, M
    Saffran, B
    Stinson, TJ
    Nelson, W
    Bennett, CL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (15): : 1453 - 1457
  • [2] When is Cancer Care Cost-Effective? A Systematic Overview of Cost-Utility Analyses in Oncology
    Greenberg, Dan
    Earle, Craig
    Fang, Chi-Hui
    Eldar-Lissai, Adi
    Neumann, Peter J.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (02): : 82 - 88
  • [3] IMS Institute for Healthcare Informatics, INN CANC CAR IMPL HL
  • [4] Pharmacoeconomic analyses - Making them transparent, making them credible
    Rennie, D
    Luft, HS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (16): : 2158 - 2160
  • [5] Skills of the Trade: The Tufts Cost-Effectiveness Analysis Registry
    Thorat, Teja
    Cangelosi, Michael
    Neumann, Peter J.
    [J]. JOURNAL OF BENEFIT-COST ANALYSIS, 2012, 3 (01)
1